Viz.ai, Inc.: Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm

New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it

Related Keywords

United States ,Americans ,Jayme Strauss ,Philip Batista ,Laurie Masonson ,Centers For Disease ,Drug Administration ,Business Wire ,Associate Program Director ,Endovascular Surgery Residency ,Trihealth Vascular Surgeon ,Disease Control ,Viz Platform ,Diese Gold Aktie ,Sichern Sie ,First ,Eceive ,Clearance ,Algorithm ,Prabdominal ,Aortic ,Aneurysm ,